期刊文献+

甲磺酸罗哌卡因用于幼儿臂丛神经阻滞的浓度选择

Ropivacaine Mesylate Injection Uses in the Density Choice which a Baby Arm Clump of Nerve Hinders
下载PDF
导出
摘要 目的:探讨甲磺酸罗哌卡因用于幼儿臂丛神经阻滞的最佳浓度。方法:将80例行臂丛神经阻滞的幼儿患者,随机分为4组,每组20例。均在全麻下用甲磺酸罗哌卡因。浓度分别为0.33%、0.25%、0.20%、0.167%,容量为1ml/kg,观察临床麻醉效果及不良反应。结果:0.167%组浓度较低,阻滞效果较其他三组差。0.33%组有2例出现肢体不自主运动。结论:0.2%、0.25%、0.33%甲磺酸罗哌卡因均可以安全地用于幼儿臂丛神经阻滞,0.33%甲磺酸罗哌卡因要注意防止局麻药中毒。 Objective:Discusses a baby arm clump of nerve hinder with ropivacaine mesylate injection of density choice.Methods:Baby patient who hinders 80 routine arm clump of nerve,divided into 4 groups stochastically,each group of 20 examples.Uses ropivacaine mesylate injection under the general anesthesia.The density respectively is 0.33%,0.25%,0.20%,0.167%,and the capacity is 1ml/kg.Observation clinical anesthesia effect and the side effect.Results: The density of 0.167% group hinder effect difference to compare other three groups.0.33% group have 2 cases to present the body involuntary movement.Conclusion:0.2%,0.25%,0.33% ropivacaine mesylate injection may safe use in a baby arm clump of nerve hindering.0.33% ropivacaine mesylate injection must pay attention to the prevention local anesthetic poisoning.
出处 《医学理论与实践》 2010年第6期640-641,共2页 The Journal of Medical Theory and Practice
关键词 甲磺酸罗哌卡因 幼儿 臂丛神经阻滞 药物浓度 Ropivacaine mesylate injection Baby An arm clump of nerve hinders Medicine density
  • 相关文献

参考文献5

二级参考文献23

  • 1徐仲煌,黄宇光,任洪智,叶铁虎,罗爱伦.神经刺激器定位神经阻滞在临床麻醉中的应用[J].临床麻醉学杂志,2001,17(5):278-279. 被引量:116
  • 2Hickey R, Candido KD, Ramamurthy S, et al. Brachial plexus block with a new local anaesthetic: 0.5% ropivacaine. Can J Anaesth,1990, 37:732 - 735.
  • 3Ivam G, Mereto N, Lampugnani E, et al. Ropivacaine in paediatric-surgery:Preliminary results. Paediatr Anaesth, 1998, 8:127 - 130.
  • 4Carre P, Joly A, Cluzel B, et al. Axillary block in children:single or multiple injection. Paediatr Anaesth, 2000, 10:35 - 39.
  • 5Ekatodramis G, Borgeat A, Huledal G, et al. Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery. Anesthesiology, 2003, 98: 143-150.
  • 6Reif S, Le Corre P, Dollo G, et al. High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2' ,6'-pipecoloxylidide in plasma. J Chromatogr B Biomed Sci Appl, 1998, 719: 239-244.
  • 7Pere P, Salonen M, Jokinen M, et al. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesth Analg, 2003, 96: 563-569.
  • 8Burm AG, Stienstra R, Brouwer RP, et al. Epidural infusion of ropivacaine for postoperative analgesia after major orthopedic surgery: pharmacokinetic evaluation. Anesthesiology, 2000, 93:395-403.
  • 9Scott DA,Chamley DM,Mooney PH,et al.Epidural ropivacaine infusion for postoperative analgesia after major lower abdominal surgery a dose finding study.Anesth Analg,1995,81:982-986.
  • 10Feldman HS.Toxicity of local anesthetic agents.In:Rice SA,Fish KJ,eds.Anesthetic toxicity,1th edn.New York:Raven Press,1994.107-132.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部